Inhaled Extracellular Vesicle Therapeutics for Respiratory Diseases – Optimisation and Characterisation

Time: 1:30 pm
day: Day 2


  • Delving into essential characterisation of extracellular vesicles to assess the impact of the administration method
  • Assessing current roadblocks in preclinical models due to lack of relevant methods of administration
  • Investigating extracellular vesicle surface modification for improved targeted delivery to the lung